Back to search

Article

Pentoxifylline, a Non-Antibiotic Drug, Promotes Adaptation of Clinical Isolates of <i>Staphylococcus aureus</i> via Modulating c-di-AMP Signaling

2025-09-09

Abstract excerpt

This study investigated how Staphylococcus aureus adapts under pentoxifylline (PTX) therapy through analyzing three phylogenetically related isolates (L1, L2, L3) from a bacteremia patient. Whole genome sequencing revealed L1 contained a 2400-bp insertion disrupting nupC , while L3 harbored mutations in the anti-Shine-Dalgarno sequences of 16S rRNA. Each isolate evolved distinct mechanisms to reduce c-di-AMP lev...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8e4ce578-dc0f-5d39-8a52-d5c139e147b0
DOI
10.1101/2025.09.09.675175
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pentoxifylline, a Non-Antibiotic Drug, Promotes Adaptation of Clinical Isolates of <i>Staphylococcus aureus</i> via Modulating c-di-AMP SignalingDOI 10.1101/2025.09.09.675175
Select a neighboring publication to make it the new centre.